One of the health highlights mentioned in this update compiled by editors outlines the conclusions from a recent ISMP QuarterWatch report that examined many unanswered questions about the safety and effectiveness of pimavanserin (Nuplazid), a drug used to treat psychosis in Parkinson's patients, and called for stronger warnings on its label.
For the full text, visit U.S. News & World Report online.
More News
Regularly scheduled boosters are the most effective way to maintain normalcy in an endemic
New Recommendations Focus on Safe Use of Technology
This article from Kaiser Health News appeared on the CNN website on April 28, 2022.